Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS).
about
Childhood Immune Thrombocytopenia: Long-term Follow-up Data Evaluated by the Criteria of the International Working Group on Immune Thrombocytopenic PurpuraManagement of patients with refractory immune thrombocytopenic purpura.A clinical score predicting a brief and uneventful course of newly diagnosed idiopathic thrombocytopenic purpura in children.Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpuraNovel clearance mechanisms of platelets.Romiplostim in children with chronic refractory ITP: randomized placebo controlled study.Applicability of 2009 international consensus terminology and criteria for immune thrombocytopenia to a clinical pediatric populationManagement of immune thrombocytopenic purpura in children: potential role of novel agents.Rapid update on childhood immune thrombocytopenic purpure.Duration and morbidity of chronic immune thrombocytopenic purpura in children: five-year follow-up of a Nordic cohort.Prevalence of primary immune thrombocytopenia in Oklahoma.Determining a definite diagnosis of primary immune thrombocytopenia by medical record review.Management of children and adolescents with primary immune thrombocytopenia: controversies and solutions.CD4+ CD25+High Foxp3+ regulatory T cells, B lymphocytes, and T lymphocytes in patients with acute ITP in Assiut Children Hospital.Immune thrombocytopenia in the elderly: clinical course in 525 patients from a single center in China.Spontaneous improvement of chronic immune thrombocytopenia in children: experience of 56 patients at a single institute.Update on the Intercontinental Cooperative ITP Study Group (ICIS) and on the Pediatric and Adult Registry on Chronic ITP (PARC ITP).Immune thrombocytopenic purpura: historical perspective, current status, recent advances and future directions.Absolute lymphocyte counts as prognostic indicators for immune thrombocytopenia outcomes in children.Evaluation of health related quality of life in children with immune thrombocytopenia with the PedsQL™ 4.0 Generic Core Scales: a study on behalf of the pays de Loire pediatric hematology network.Guidelines on the diagnosis of primary immune thrombocytopenia in children and adolescents: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2012.Clinical practice: immune thrombocytopenia in paediatrics.Identification of predictive factors for response to intravenous immunoglobulin treatment in children with immune thrombocytopenia.Helicobacter pylori infection & immune thrombocytopenic purpura in children and adolescents: A randomized controlled trial.Comparative of three methods (ELIZA, MAIPA and flow cytometry) to determine anti-platelet antibody in children with ITP.A Study of Human Killer Cell Immunoglobulin-Like Receptor and Multidrug Resistance Gene Polymorphisms in Children With Immune Thrombocytopenia.Association of CD4(+)CD25(+)FoxP3(+) regulatory T cells with natural course of childhood chronic immune thrombocytopenic purpuraB-cell hyperfunction in children with immune thrombocytopenic purpura persists after splenectomy.High Remission Rate of Chronic Immune Thrombocytopenia in Children: Result of 20-Year Follow-Up.Multicenter Cohort Study Comparing U.S. Management of Inpatient Pediatric Immune Thrombocytopenia to Current Treatment Guidelines.Hospitalizations in pediatric patients with immune thrombocytopenia in the United States.Health-related quality of life in children with chronic immune thrombocytopenia in China.Clinical Features and Treatment Outcomes of Primary Immune Thrombocytopenic Purpura in Hospitalized Children Under 2-Years Old.Delayed-onset thrombocytopenia in a pediatric burn patient.Predictive factors for resolution of childhood immune thrombocytopenia: Experience from a single tertiary center in Thailand.Tolerability and Efficacy of Eltrombopag in Chronic Immune Thrombocytopenia.Childhood immune thrombocytopenia: A nationwide cohort study on condition management and outcomes.Predictors of remission in children with newly diagnosed immune thrombocytopenia: Data from the Intercontinental Cooperative ITP Study Group Registry II participants.The effect of anti-thyroid antibodies positivity on children with primary immune thrombocytopenia.Thrombopoietin-receptor agonists for children with immune thrombocytopenia: a systematic review.
P2860
Q30808680-C94FC83C-1EB3-4FC7-B3F7-297482316A2DQ33372113-7447D700-593F-4568-91B9-261E4D0859F1Q33375767-117B8983-94CE-4458-A574-3DC1F603BBEAQ33380732-DBA3CB2B-FA21-4862-9AC3-5453CCE60338Q33391541-268C3FDC-3843-498D-9825-CA69E6FEC104Q33394122-A88DD10D-0C2A-4B49-96D0-24FACB138A11Q33395789-7FE39183-F143-4014-B566-5B9FE55024D5Q33395863-56E34567-6838-48C8-878E-C39AA240687BQ33397751-EB8423E6-1DB3-497C-BB00-FEDB6AB2C7D9Q33400296-0FF673EF-C8EF-4C15-9374-BDE7E45AD115Q33401671-B368FDAA-4A72-43CA-A4EF-3F3710664314Q33401893-652DC0F0-5F47-4D4A-8FCE-8B9BFE1E6921Q33402387-C98082F6-1E36-43BA-AE5C-2977201CE78EQ33402738-D279FCA3-3186-4B3D-8777-6644CE031777Q33403176-B9E861B3-6959-4227-978C-43A99DEFCDC9Q33404073-96C66061-0B66-41BF-BD5E-4D4E99DF3202Q33404097-A01D0979-82F1-4A2C-8178-12596F357153Q33404315-98CC642F-6CE8-444A-9559-96CAD93A79BAQ33410356-DC26D96C-762D-42BA-9957-71085B1676FFQ33411434-E0740612-77EC-4436-B90B-6C80877DB5DFQ33411617-DDF40FD2-FFEF-4455-B25B-44EB2F102407Q33412475-D7D57661-FBEA-47C1-980F-D00CE0687A52Q33413528-B2521EB5-E481-47FA-8BB6-60949932234EQ33415361-80CCD600-1556-43B7-9218-BBA5BC26F62CQ33421049-EE83CDFC-3F29-41B2-A979-C93E01EB52BEQ33421329-7B088216-76F4-4417-A912-D53FA7A476D1Q33423983-A29590E2-2317-45B7-A750-4D0393E2DB0BQ33426961-CBFB42A0-C495-4E93-97BE-BF1BE7CABF96Q33428115-F63FE5E9-F2C7-401A-9538-91841C6270B3Q33430385-51E509B2-6CA3-46BA-AC79-A8A18FDE47A2Q33430486-66CB3E2C-ACE4-4B87-B42A-0AD1AD4D64C9Q33430741-A1223FB4-7E41-46F1-A46A-FDF6D8ED4E02Q33432482-60C1D898-993B-4492-8CE2-A5C7C9CEAA2EQ33432859-34623E83-7886-43C6-BE02-D24E8948C61EQ33434921-A34F0B3A-103B-4A8E-8D2A-FCCCAB4CC5EEQ33434927-B40B8764-3FB5-45CD-877B-7E513AE71B1BQ33437268-2CC14B22-BCFE-4115-A464-C3F13BB459DCQ38632350-BC647148-B893-4F89-91F3-B6D34AE85375Q46472839-7B16BD76-D42E-485F-9F55-705146F74053Q47898156-3140E5E3-1B0A-434B-9287-1D21E0231F42
P2860
Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS).
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Childhood ITP: 12 months follo ...... ldhood ITP Study Group (ICIS).
@ast
Childhood ITP: 12 months follo ...... ldhood ITP Study Group (ICIS).
@en
type
label
Childhood ITP: 12 months follo ...... ldhood ITP Study Group (ICIS).
@ast
Childhood ITP: 12 months follo ...... ldhood ITP Study Group (ICIS).
@en
prefLabel
Childhood ITP: 12 months follo ...... ldhood ITP Study Group (ICIS).
@ast
Childhood ITP: 12 months follo ...... ldhood ITP Study Group (ICIS).
@en
P2093
P356
P1476
Childhood ITP: 12 months follo ...... ldhood ITP Study Group (ICIS).
@en
P2093
Berchtold W
Buchanan GR
Zimmerman S
P304
P356
10.1002/PBC.20453
P577
2006-03-01T00:00:00Z